Dimitrios C. Mastellos

Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Panagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou et al. · Journal of Clinical Investigation · 2020 · 768 citations · Full text

Innate Immune System, Immunology, Pathology +23

A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways

Konstantinos Ritis, Michael Doumas, Dimitrios C. Mastellos et al. · The Journal of Immunology · 2006 · 475 citations

The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration

Christoph W. Strey, Maciej M. Markiewski, Dimitrios C. Mastellos et al. · The Journal of Experimental Medicine · 2003 · 423 citations · Full text

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Sara Mastaglio, Annalisa Ruggeri, Antonio M. Risitano et al. · Clinical Immunology · 2020 · 287 citations · Full text

Complement System, Covid-19 Pandemic, Immunology +7

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Dimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca et al. · Clinical Immunology · 2020 · 256 citations · Full text

Complement System, Differential Biological Efficacy, Covid-19 Pandemic +8